The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation

0 Cummings, S. R. Eckert, S. Krueger, K. A. Grady, D. Powles, T. J. Cauley, J. A. Norton, L. Nickelsen, T. Bjarnason, N. H. Morrow, M. Lippman, M. E. Black, D. Glusman, J. E. Costa, A. Jordan, V. C. 1999 The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation Jama 281 2189-97 10376571 Aged, Breast Neoplasms/*epidemiology/metabolism, Double-Blind Method, Endometrial Neoplasms/epidemiology, Estrogen Antagonists/adverse effects/*therapeutic use, Estrogens/*agonists, Female, Follow-Up Studies, Humans, Osteoporosis, Postmenopausal/*drug the http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10376571